Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)

Go to Funding Search

Key Information

Due Date: December 4, 2026


Agency: U.S. Department of Health and Human Services (HHS)


Source: Federal


Funding Category:

Health & Human Services

Funding Amount: Not Specified


Funding Type: Grant


Match Required: No


Contact Info: grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.

Overview

This text is about a Notice of Funding Opportunity (NOFO) called the Planning for Product Development Strategy (R34 Clinical Trial Not Allowed). Its goal is to offer financial support to help create detailed and comprehensive plans regarding the development of new treatments for HIV and related comorbidities, coinfections, and complications.

The funding also covers the development of preventive strategies for HIV and is aimed at aiding the transformation of research findings into drug products. The ultimate target of this strategy is to compile and submit an Investigational New Drug (IND) application to the Food and Drug Administration (FDA), thus promoting the launch of new drug treatments in the healthcare market.

Show More

Key Dates

Open Date: August 14, 2023


Application Due Date: December 4, 2026


Estimated Award Date: Not Specified

Additional Details

Eligible Activities

  • Research and Development

Eligible Applicants

  • State governments
  • County governments
  • City, village or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Private institutions of higher education
  • Small businesses

Search MI Funding Hub

NOTE: Site search does not include grant search. See Find Funding page for grant searching.